Alak Manna

机构：WinnMed, Cancer Clinic, Mayo Clinic in Florida · ORCID：0000-0003-3894-3277

发表论文 73 篇 · 总被引 799 次 · h-index 17

代表论文

• Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy (2022 · Clinical Cancer Research · 被引 56)
• Targeting CD38 is lethal to Breg-like chronic lymphocytic leukemia cells and Tregs, but restores CD8+ T-cell responses (2020 · Blood Advances · 被引 37)
• Translational development of a novel BAFF-R CAR-T therapy targeting B-cell lymphoid malignancies (2023 · Cancer Immunology Immunotherapy · 被引 19)
• Influence of polymorphisms in TNF-α and IL1β on susceptibility to alcohol induced liver diseases and therapeutic potential of miR-124-3p impeding TNF-α/IL1β mediated multi-cellular signaling in liver microenvironment (2023 · Frontiers in Immunology · 被引 13)
• Prospect of CAR T-cell therapy in acute myeloid leukemia (2022 · Expert Opinion on Investigational Drugs · 被引 10)
• AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma (2023 · Cancers · 被引 6)